Posterior left pericardiotomy reduces postoperative atrial fibrillation in patients undergoing coronary artery bypass

Nikhil Sahdev1, Guiqing Liu1, Sahar Hasanzade1

  • 1Department of Cardiothoracic Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

JTCVS Open
|July 9, 2025
PubMed

Insights

Posterior pericardiotomy significantly reduces the risk and duration of postoperative atrial fibrillation (POAF) after coronary artery bypass grafting. This surgical technique offers a promising approach to mitigate this common complication.

Area of Science:

  • Cardiac Surgery
  • Cardiology
  • Thoracic Surgery

Background:

  • Postoperative atrial fibrillation (POAF) is a frequent complication following coronary artery bypass grafting (CABG), increasing morbidity and mortality.
  • Posterior pericardiotomy (PP) has shown potential in reducing POAF, but its widespread clinical adoption and real-world effectiveness require further investigation.

Purpose of the Study:

  • To evaluate the impact of posterior pericardiotomy (PP) on the incidence and cumulative burden of postoperative atrial fibrillation (POAF) in a real-world setting.
  • To assess the association between PP and POAF in patients undergoing CABG surgery.

Main Methods:

  • A retrospective analysis of 2,480 patients who underwent CABG surgery between 2015 and 2022.
  • Comparison of POAF incidence and duration between patients who had PP (n=806) and a control group without PP (n=1674).
  • PP involved a 5-cm incision between the left inferior pulmonary vein and the phrenic nerve.

Main Results:

  • Posterior pericardiotomy was associated with a 27.4% reduction in the odds of developing POAF (OR, 0.73; P=.023).
  • Age was a significant risk factor for POAF (OR, 1.04 per year; P<.001).
  • In multivariate analysis, PP remained protective, reducing POAF odds by 26.9% (OR, 0.73; P=.028), and significantly decreased POAF duration by 5.3% (P=.002).

Conclusions:

  • Posterior pericardiotomy is an effective intervention for reducing both the likelihood and duration of postoperative atrial fibrillation after CABG.
  • Further large-scale, multicenter trials are warranted to confirm these findings and explore the impact of PP on post-discharge outcomes.
Abstract